Bioptimus: Pioneering AI in Biology

Bioptimus, a Paris-based biotech startup, has secured a hefty $35 million in seed funding to propel its groundbreaking AI foundational model focused on biology. Led by CEO Jean-Philippe Vert, the company aims to revolutionize scientific research and biotechnological innovation by connecting different biological scales with generative AI. With a team of experts from Google DeepMind and partnerships with academic hospitals worldwide, Bioptimus is poised to make a significant impact in the biotech research community. The future looks bright as Bioptimus sets out to improve disease diagnosis, precision medicine, and create new biomolecules for medical and environmental applications.